OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk between IL‐15Rα+tumor‐associated macrophages and breast cancer cells reduces CD8+T cell recruitment
Wenlong Zhang, Qing Zhang, Nanfei Yang, et al.
Cancer Communications (2022) Vol. 42, Iss. 6, pp. 536-557
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 498

Macrophage barrier in the tumor microenvironment and potential clinical applications
Shuai Ji, Yuqing Shi, Bo Yin
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 29

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages
Xiangyuan Chu, Yu Tian, Chao Lv
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18

Cancer-Associated Adipocytes and Breast Cancer: Intertwining in the Tumor Microenvironment and Challenges for Cancer Therapy
Chenghui Wu, Shuwen Dong, Renhong Huang, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 726-726
Open Access | Times Cited: 29

Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives
Yunchao Zhang, Chenxin Liu, Chunjie Wu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114257-114257
Open Access | Times Cited: 27

Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 234-234
Open Access | Times Cited: 1

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1

Metabolic interplay: tumor macrophages and regulatory T cells
Stefania Vilbois, Yingxi Xu, Ping‐Chih Ho
Trends in cancer (2023) Vol. 10, Iss. 3, pp. 242-255
Closed Access | Times Cited: 20

Immunomodulatory Peptides for Tumor Treatment
Yang Song, Longtianyang Lei, Xingyu Cai, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 6

Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer
Jun Liu, Jiaye Lu, Ling Wu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5

Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors
Jiawei Fan, Jianshu Zhu, He Zhu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104362-104362
Open Access | Times Cited: 5

Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5

Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion
Alessia Zotta, Juliana E. Toller-Kawahisa, Eva M. Pålsson‐McDermott, et al.
Science Advances (2025) Vol. 11, Iss. 4
Open Access

Development and Validation of a Basement Membrane Inflammatory Response Gene Signature in Lung Adenocarcinoma
Shilei Liu, Fei Liao, Qingming Xie, et al.
Research Square (Research Square) (2025)
Closed Access

HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, −10 and −11
Yixi Su, Jiaqi Liu, Yu Tian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116427-116427
Open Access | Times Cited: 4

ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4+ macrophage infiltration
Caihua Zhang, Kang Li, Hongzhang Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

Artificial intelligence in tumor drug resistance: Mechanisms and treatment prospects
Jianyou Gu, Junfeng Zhang, Silüe Zeng, et al.
(2025)
Closed Access

Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy
Hong Jin, Xinyue Meng, Jianwei Feng
Frontiers in Immunology (2025) Vol. 16
Open Access

Fractalkine in Health and Disease
Claudia Rodríguez, Luisa Chocarro, Miriam Echaide, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8007-8007
Open Access | Times Cited: 3

TS‐2021, a third‐generation oncolytic adenovirus that carried Ki67 promoter, TGF‐β2 5′UTR, and IL−15 against experimental glioblastoma
Jialin Wang, Junwen Zhang, Qing Zhang, et al.
Journal of Medical Virology (2023) Vol. 96, Iss. 1
Closed Access | Times Cited: 6

Page 1 - Next Page

Scroll to top